companydata.dkELDON BIOLOGICALS A/S: Financial statements 2016
CVR: 26747007
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 6,073,914 and a net result of DKK 1,219,431 compared with DKK 1,501,774 the year before. That is an increase of 0.2% compared with the year before. Equity amounted to DKK 1,271,623. The solvency ratio was 19.8%.
- Gross Profit
- 6,073,914 kr.
- Profit/Loss
- 1,219,431 kr.
- Equity
- 1,271,623 kr.
- Total Assets
- 6,407,394 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 6.1 mio. | 1.2 mio. | 1.3 mio. | - |
| 2015 | - | 6.1 mio. | 1.5 mio. | 319 t. | - |
| 2014 | - | 4.9 mio. | 1.1 mio. | -1.2 mio. | - |
| 2013 | - | 4.1 mio. | 949 t. | -2.3 mio. | - |
How creditworthy is ELDON BIOLOGICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
As of September 13, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of ELDON BIOLOGICALS A/S.
As of September 13, 2016, REVISIONSFIRMAET SLEIMANN ApS has stepped down as auditor of ELDON BIOLOGICALS A/S.
About ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity amounted to DKK 42,055,949.